Literature DB >> 7506687

Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli.

T M Kozlovska1, I Cielens, D Dreilinņa, A Dislers, V Baumanis, V Ose, P Pumpens.   

Abstract

The Escherichia coli RNA phage Q beta coat protein-encoding gene (C) was amplified from native Q beta RNA using a reverse transcription-PCR technique. Gene C contains sequences coding for both the 133-amino acid (aa) Q beta coat protein (CP) and the 329-aa read-through protein (A1) consisting of CP and an additional 196-aa C-terminal sequence, separated from CP within the C gene by an opal (UGA) stop codon. Primers ensuring the natural environment for gene C, especially within the ribosome-binding site, and supplying C with unique restriction sites at both ends have been prepared. An amplified 1062-bp PCR fragment was positioned under the control of the strong E. coli trp promoter (Ptrp) within a pGEM-derived plasmid. The synthesis of gene C products was confirmed electrophoretically and immunologically. An immunodiffusion test with anti-Q beta phage antibodies and electron microscopy evaluation of the purified recombinant products showed that when expressed, the Q beta C gene was responsible for high-level synthesis and correct self-assembly of Q beta CP monomers into capsids indistinguishable morphologically and immunologically from Q beta phage particles, which we plan to use as surface display vectors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506687     DOI: 10.1016/0378-1119(93)90261-z

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  30 in total

1.  Evolution of bacteriophage in continuous culture: a model system to test antiviral gene therapies for the emergence of phage escape mutants.

Authors:  Björn F Lindemann; Christian Klug; Andreas Schwienhorst
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.

Authors:  Duane E Prasuhn; Pratik Singh; Erica Strable; Steven Brown; Marianne Manchester; M G Finn
Journal:  J Am Chem Soc       Date:  2008-01-05       Impact factor: 15.419

Review 3.  Therapeutic vaccines for chronic diseases: successes and technical challenges.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

4.  Random removal of inserts from an RNA genome: selection against single-stranded RNA.

Authors:  R C Olsthoorn; J van Duin
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Glycan-targeted virus-like nanoparticles for photodynamic therapy.

Authors:  Jin-Kyu Rhee; Michael Baksh; Corwin Nycholat; James C Paulson; Hiroaki Kitagishi; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-24       Impact factor: 6.988

6.  Crystal structure of the read-through domain from bacteriophage Qβ A1 protein.

Authors:  Janis Rumnieks; Kaspars Tars
Journal:  Protein Sci       Date:  2011-08-18       Impact factor: 6.725

7.  Stabilization of virus-like particles with poly(2-oxazoline)s.

Authors:  Florian Manzenrieder; Robert Luxenhofer; Marco Retzlaff; Rainer Jordan; M G Finn
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-20       Impact factor: 15.336

8.  On-virus construction of polyvalent glycan ligands for cell-surface receptors.

Authors:  Eiton Kaltgrad; Mary K O'Reilly; Liang Liao; Shoufa Han; James C Paulson; M G Finn
Journal:  J Am Chem Soc       Date:  2008-03-15       Impact factor: 15.419

9.  Versatile virus-like particle carrier for epitope based vaccines.

Authors:  Alain C Tissot; Regina Renhofa; Nicole Schmitz; Indulis Cielens; Edwin Meijerink; Velta Ose; Gary T Jennings; Philippe Saudan; Paul Pumpens; Martin F Bachmann
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  Engineered mutations change the structure and stability of a virus-like particle.

Authors:  Jason D Fiedler; Cody Higginson; Marisa L Hovlid; Alexander A Kislukhin; Alexandra Castillejos; Florian Manzenrieder; Melody G Campbell; Neil R Voss; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-25       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.